Evidence map›Paper›PMID 31906315›Full record

ArticleDiagnostics (Basel, Switzerland)2020

Digital Microfluidic Platform to Maximize Diagnostic Tests with Low Sample Volumes from Newborns and Pediatric Patients.

Rama S Sista, Rainer Ng, Miriam Nuffer, Michael Basmajian, Jacob Coyne, Jennifer Elderbroom, Daniel Hull, Kathryn Kay, Maithri Krishnamurthy, Christopher Roberts and 5 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Rama S SistaBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Rainer NgBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Miriam NufferBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Michael BasmajianBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Jacob CoyneBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Jennifer ElderbroomBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Daniel HullBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Kathryn KayBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Maithri KrishnamurthyBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Christopher RobertsBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Daniel WuBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Adam D KennedyBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Rajendra SinghBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Vijay SrinivasanBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Vamsee K PamulaBaebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Baebies (United States) · US

Funding

Multiplex Platform for Point-of-Care Newborn Screening of HyperbilirubinemiaR44HD072853 · NICHD · BAEBIES, INC. · PI PAMULA, VAMSEE K. · 2016 to 2020
$3.4M
Expanding thyroid testing in high risk newborns: total T3, free T4, TSH and TRABR44HD093494 · NICHD · BAEBIES, INC. · PI SINGH, RAJENDRA · 2017 to 2019
$1.9M
Comprehensive, Near Patient Assessment of Severe Hypoglycemia in Newborns Using Low Blood VolumeR44HD092154 · NICHD · BAEBIES, INC. · PI PAMULA, VAMSEE K. · 2017 to 2019
$1.8M
Near Patient Acute Kidney Injury Biomarker Analysis in Critically Ill NeonatesR44HD095225 · NICHD · BAEBIES, INC. · PI PAMULA, VAMSEE K. · 2018 to 2020
$1.8M
An Innovative Unbound Bilirubin Assay to Identify Bilirubin-Induced Neurological Dysfunction (BIND) Risk as Part of a Comprehensive and Novel Point-of-Care Newborn Screening PanelR44HL146016 · NHLBI · BAEBIES, INC. · PI ELDERBROOM, JENNIFER · 2019 to 2021
$1.7M
Rapid, Near Patient Nucleic Acid Testing for Congenital Cytomegalovirus (CMV) InfectionR44DC016576 · NIDCD · BAEBIES, INC. · PI PAMULA, VAMSEE K. · 2017 to 2018
$1.5M
Eunice Kennedy Shriver National Institute of Child Health and Human Development R44HD072853Eunice Kennedy Shriver National Institute of Child Health and Human Development R44HD092154Eunice Kennedy Shriver National Institute of Child Health and Human Development R44HD093494Eunice Kennedy Shriver National Institute of Child Health and Human Development R44HD095225NHLBI NIH HHS R44HD093494NHLBI NIH HHS R44HL146016NIDCD NIH HHS R44DC016576
6 · The paper itself

Abstract

"Children are not tiny adults" is an adage commonly used in pediatrics to emphasize the fact that children often have different physiological responses to sickness and trauma compared to adults. However, despite widespread acceptance of this concept, diagnostic blood testing is an excellent example of clinical care that is not yet customized to the needs of children, especially newborns. Cumulative blood loss resulting from clinical testing does not typically impact critically ill adult patients, but can quickly escalate in children, leading to iatrogenic anemia and related comorbidities. Moreover, the tests prioritized for rapid, near-patient testing in adults are not always the most clinically relevant tests for children or newborns. This report describes the development of a digital microfluidic testing platform and associated clinical assays purposely curated to address current shortcomings in pediatric laboratory testing by using microliter volumes (<50 µL) of samples. The automated platform consists of a small instrument and single-use cartridges, which contain all reagents necessary to prepare the sample and perform the assay. Electrowetting technology is used to precisely manipulate nanoliter-sized droplets of samples and reagents inside the cartridge. To date, we have automated three disparate types of assays (biochemical assays, immunoassays, and molecular assays) on the platform and have developed over two dozen unique tests, each with important clinical application to newborns and pediatric patients. Cell lysis, plasma preparation, magnetic bead washing, thermocycling, incubation, and many other essential functions were all performed on the cartridge without any user intervention. The resulting assays demonstrate performance comparable to standard clinical laboratory assays and are economical due to the reduced hands-on effort required for each assay and lower overall reagent consumption. These capabilities allow a wide range of assays to be run simultaneously on the same cartridge using significantly reduced sample volumes with results in minutes.

Indexed as

albuminbilirubincreatininecytomegalovirusdigital microfluidicselectrowettingglucose-6-phosphate dehydrogenaseinsulinlaboratorynanoliterneonatal intensive care unit (NICU)pediatricsthyroid

Identifiers

PMID31906315
PMCPMC7169462
OpenAlexW2998070878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.